Pharmaceuticals (TRBC)

Aclaris’s drug to treat common skin growth gets FDA nod

Aclaris’s drug to treat common skin growth gets FDA nod

Published 15/12/2017

(Reuters) - Aclaris Therapeutics Inc’s drug to treat a common kind of skin growth called seborrheic keratoses received approval from the U.S. Food and Drug [more…]

FDA allows Alnylam to restart hemophilia treatment trials

FDA allows Alnylam to restart hemophilia treatment trials

Published 15/12/2017

(Reuters) - The U.S. Food and Drug Administration has allowed Alnylam Pharmaceuticals Inc to restart clinical trials on a drug to treat patients with a [more…]

Antibiotics sales for use in U.S. farm animals dropped in 2016: FDA

Antibiotics sales for use in U.S. farm animals dropped in 2016: FDA

Published 08/12/2017

FILE PHOTO: Turkeys stand in the warmth of the sun in their barn at Seven Acres Farm in North Reading, Massachusetts November 24, 2015, two [more…]

Sage shares surge as depression drug succeeds in mid-stage trial

Sage shares surge as depression drug succeeds in mid-stage trial

Published 07/12/2017

(Reuters) - Drug developer Sage Therapeutics Inc’s shares soared as much as 85 percent to a record high on Thursday after its experimental drug to [more…]

Indivior drug to fight opioid addiction approved by U.S. FDA

Indivior drug to fight opioid addiction approved by U.S. FDA

Published 01/12/2017

(Reuters) - Indivior’s experimental drug to help fight America’s growing opioid addiction crisis was approved by the U.S. Food and Drug Administration late on Thursday, [more…]

Bayer pharmaceuticals head says there’s no pipeline problem

Bayer pharmaceuticals head says there’s no pipeline problem

Published 23/11/2017

LEVERKUSEN, Germany (Reuters) - Bayer is seeking to defend its pharmaceuticals business that will be diluted in importance by the takeover of Monsanto and faces [more…]

Roche announces trial successes in cancer, haemophilia

Roche announces trial successes in cancer, haemophilia

Published 20/11/2017

FILE PHOTO: FILE PHOTO: Swiss drugmaker Roche's logo is seen at their headquarters in Basel, Switzerland January 28, 2016. REUTERS/Arnd Wiegmann/File PhotoZURICH (Reuters) - Roche [more…]

Trump taps ex-pharma executive Azar as U.S. health secretary

Trump taps ex-pharma executive Azar as U.S. health secretary

Published 13/11/2017

President Donald Trump on Monday said he is nominating former pharmaceutical executive and industry lobbyist Alex Azar to serve as U.S. Health and Human Services secretary, saying Azar would push to lower the price of medicines. [more…]

Dynavax`s hepatitis B vaccine gets FDA nod on third try, shares up

Dynavax`s hepatitis B vaccine gets FDA nod on third try, shares up

Published 09/11/2017

Dynavax Technologies Corp's hepatitis B vaccine won the U.S. Food and Drug Administration's approval on the third attempt and Chief Executive Eddie Gray told Reuters the company was open to, but not waiting for, a partner to market the drug. [more…]

U.S. healthcare brightens tame U.S. high-grade M&A lending

U.S. healthcare brightens tame U.S. high-grade M&A lending

Published 03/11/2017

CVS Health Corp’s planned US$66bn buy of Aetna Inc is poised to boost the healthcare sector’s share of US investment-grade mergers and acquisitions lending beyond its current one-third share of the US$122bn total as the sector remains a bright spot in an otherwise lackluster market. [more…]